Showing 291-300 of 6901 results for "".
A Young Iraqi Girl’s Long-Term Prognosis After Heart Surgery
https://reachmd.com/programs/clinicians-roundtable/a-young-iraqi-girls-long-term-prognosis-after-heart-surgery/2612/Despite the tremendous conflict in Iraq, there have been many medical miracles. One such story centers around Amenah Al-Bayati, a young Iraqi girl found ill by a United States Marine Corps battalion surgeon, who suspected the girl had a potentially life-threatening heart condition, fixable only by iManaging Your Clinical Practice Through a Recession
https://reachmd.com/programs/clinicians-roundtable/managing-your-clinical-practice-through-a-recession/2520/What can you do to survive a recession and even come out ahead afterwards? Join host Larry Kaskel in a discussion about managing a medical practice through the recession with our guest, Peter Lucash.Managing Your Moonlighting Income
https://reachmd.com/programs/clinicians-roundtable/managing-your-moonlighting-income/2483/Did you know that employed physicians who are moonlighting independently on the side may be in the best postion to minimize taxes? Join host Dr. Larry Kaskel to learn more about moonlighting income and tax strategies from our guest CPA Andrew Schwartz, Founder of the MD Taxes Network.Physicians For Human Rights: How You Can Get Involved
https://reachmd.com/programs/clinicians-roundtable/physicians-for-human-rights-how-you-can-get-involved/2215/With our special skills, ethical obligations and credible voices, health professionals are in a unique position to be human rights advocates. What is being done and how can you get involved? Past president of the board of directors of Physicians for Human Rights, Dr. Holly Atkinson tells host Dr. LePandemic Flu. How Will Your Hospital Respond?
https://reachmd.com/programs/clinicians-roundtable/pandemic-flu-how-will-your-hospital-respond/1992/What would happen at your ER if a quarter of the staff were sick, and hundreds of people began streaming in with a highly infectious and potentially lethal influenza. Dr. Gregory Gilbert, an Emergency Medicine specialist at Stanford University, discusses the role physicians play in helping their hoStreamlining Billings and Collections in your Practice
https://reachmd.com/programs/clinicians-roundtable/streamlining-billings-and-collections-in-your-practice/1628/Do you want to know how to streamline your billing and collection practices? Host Larry Kaskel interviews medical practice consultant Elizabeth Woodcock to learn ways to improve the process of billing and collection in a physicians office.Writing Your Renewal Rx
https://reachmd.com/programs/clinicians-roundtable/writing-your-renewal-rx/1611/Sir William Osler said that “a physician who treats himself has a fool for a patient”. Does this apply to everything? Dr. Linda hawes Clever discusses ways to write your own prescription for renewal with host, Dr. Leslie Lundt.What is the Value of Your Medical Practice?
https://reachmd.com/programs/clinicians-roundtable/what-is-the-value-of-your-medical-practice/1137/Dr. Larry Kaskel is joined by Mike Ryan, founder of Medical Mergers Group. Mr. Ryan has helped thousands of medical practices improve their operations and determine the market value of their practice. Learn what how to determine what your practice may be worth and what you can do to increase the valGetting ROI from your Revenue Cycle management sol
https://reachmd.com/programs/clinicians-roundtable/getting-roi-from-your-revenue-cycle-management-sol/555/Understanding your practice management: Getting return on investment from your Revenue Cycle management solution3 Years of Real-World Data for an AD Biologic
https://reachmd.com/programs/practical-dermatology-type-ii-inflammation-journal-club/3-years-of-real-world-data-for-an-ad-biologic/50769/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Chief Medical Editor Neal Bhatia, MD, FAAD, discuss Dr. Bhatia’s article “Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-Worl